From the Sector

The CEO of SGL Carbon SE, Dr. Torsten Derr, informed the Chairman of the Supervisory Board today that he will not extend his contract, which expires on May 31, 2025. Dr. Derr will continue his duties until the new CEO is appointed, at the latest until May 31, 2025.

“SGL Carbon is once again a strong and stable company whose profitable development I will continue to work on with all my strength until the last day. But even without me, my colleague on the Board of Management, Thomas Dippold, and the team will continue to develop the company successfully. The last almost four years have always been the achievement of the entire SGL team. SGL Carbon is now sailing in stable waters and my transformation work will therefore be completed shortly,” explains Dr. Torsten Derr.

“We are grateful to Dr. Derr for talking to us early on and in a spirit of trust. This will allow us to take our time in arranging his succession. SGL Carbon can look back on three successful financial years, is financially strong and relies on a broad-based management team that continues to drive forward the expansion of the business in strong growth markets. In our appreciative discussions, Dr. Derr has promised to complete all important projects with his usual commitment until the handover of the CEO position,” says Prof. Dr. Frank Richter.

The Supervisory Board will immediately begin the search for a successor to Dr. Torsten Derr.

• Electromagnetically heatable nanomodified stent for the treatment of hollow organ tumours wins second place at the RWTH Innovation Award

Almost every fourth person who dies of cancer has a hollow organ tumour, for example in the bile duct or in the oesophagus. Such a tumour cannot usually be removed surgically. It is only possible to open the hollow organ for a short time using a stent, i.e. a tubeshaped prosthesis. However, the tumour grows back and penetrates the hollow organ through the stent. Ioana Slabu from the Institute of Applied Medical Technology and Benedict Bauer from the Institut für Textiltechnik of RWTH Aachen University have now developed a novel technology for the therapy of hollow organ tumours, which was awarded second place in the RWTH Innovation Award. This involves a polymerstent that contains magnetic nanoparticles. When electromagnetic fields are applied, these nanoparticles lead to a controlled heating of the stent material and thus of the tumour. Because the tumour reacts much more sensitively to heat than healthy tissue, it is destroyed and the hollow organ remains open. Thus, the stent develops a self-cleaning effect.  

Ioana Slabu of the AME explains: "Not only can we drastically reduce treatment costs, but above all we can provide relief for millions of patients worldwide.
 
A manufacturing process and proof of concept for magnetic hyperthermia are already in place. This novel technology has a very high development potential because it can also be used for tumours in other parts of the body such as the prostate, stomach, intestine or urinary bladder or for cardiovascular diseases.  

The AiF/IGF project started under the project title "ProNano" funded by BMWK. Now the approval for the follow-up project "ProNano2" has also been received. The approved project is called: "Validation of the innovation potential of heatable stents for heat-induced treatment of cavity tumours" and is funded by BMBF in course of the VIP+ program. With the Clinic for General, Visceral and Transplantation Surgery of the University Hospital Aachen and the Institute for Technology and Innovation Management at RWTH Aachen University, the consortium is enriched by clinical and economic expertise. Every year, RWTH Aachen University honours particularly innovative university projects with the Innovation Award. Professor Malte Brettel, Prorector for Business and Industry, presented the certificates to four outstanding projects as part of RWTHtransparent.

Klaus Heinrichs began working in marketing for the company in 1992. “From the very beginning until today Klaus used his great flair and networking skills to secure and improve the company’s international presence and public relations, especially at seven successive ITMA textile machinery exhibitions, beginning with the show in Milan in 1995,” said Monforts Marketing Manager Nicole Croonenbroek.  “Later, he also took care of customer service, sales administration and exports in his uniquely calm and quietly-spoken style.”

“He has always been a guarantor of successful product launches for Monforts technical and technological highlights such as the TwinAir principle of independent airflow regulation, the Hercules LTM stenter chain, the Econtrol® dyeing technology or the Montex®Coat device - to mention only a few.”

Klaus has also been active on the VDMA’s Exhibition and Marketing Committee since 1993, which he chaired from 2005 to 2008.  
“Klaus always enriched the industry discussions with practical and future-oriented proposals and thus also advanced ITMA,” said Thomas Waldmann, Managing Director of the VDMA Textile Machinery Association. “We sincerely thank him and wish him all the best for this new chapter of his life.”

“We will miss Klaus as a colleague and as a manager because of his skills, character and his engagement,” added Monforts Managing Director Stefan Flöth. “He truly represents the Monforts commitment to our customers to be helpful, accurate, fast and reliable, and we keep him as a friend. I’m sure the many friends he made throughout the world during his career with the company will join us in wishing him all the best for his next phase of life together with his family.”

* Econtrol is a registered trademark of Dystar Colours Distribution GmbH.

At its meeting on December 13, the Supervisory Board of Lenzing AG decided to reappoint Stefan Doboczky as Chief Executive Officer of the Management Board. Stefan Doboczky’s new contract will begin on June 1, 2018 and runs until the end of 2022.

“In recent years, Stefan Doboczky and his colleagues on the Management Board have been able to make excellent use of the favourable market conditions on the basis of the previous restructuring in order to transform an Austrian company with foreign investments into a truly global player with strong Austrian roots. This has created the basis for consistently pursuing the growth strategy we have embarked on with the entire team, even under difficult conditions, and thus securing the long-term future of the Lenzing Group. We are very pleased that Stefan Doboczky will continue to dedicate himself to these tasks over the next five years”, said Hanno Bästlein, Chairman of the Supervisory Board of Lenzing AG on the occasion of Doboczky’s reappointment.
In addition to Stefan Doboczky, the Management Board of Lenzing AG consists of Chief Commercial Officer Robert van de Kerkhof, Chief Financial Officer Thomas Obendrauf and Chief Technology Officer Heiko Arnold.